Philips
VC Fund
Amsterdam, The Netherlands
Philips is a VC fund in Amsterdam focused on Health Care and Software. Koninklijke Philips is a technology company that provides healthcare, consumer lifestyle, and lighting products, solutions, and services. The company offers professionals with healthcare, lighting, and oral healthcare products, professional dictation, and display solutions, and innovation services. It offers consumers electronic products related tosound and vision, personal care, mother and child care, housewares, lighting, PCs and phones, and more.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Philips invests in
Stages Philips invests in
Countries Philips invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Series A
- $3.5M–$51M
- Series B
- $20M–$74M
Investment Focus
Industry
- Health Care 10 (43%)
- Software 8 (35%)
- Information Technology 6 (26%)
- Medical Device 4 (17%)
- Internet 3 (13%)
Stage
- Funding Round 8 (35%)
- Series A 4 (17%)
- Series B 4 (17%)
- Series C 2 (9%)
- Corporate Round 2 (9%)
Country
- United States 13 (57%)
- China 3 (13%)
- Israel 3 (13%)
- Japan 1 (4%)
- Switzerland 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andrew Cabamalan
Commercial Operations Specialist; sales support
|
Commercial Operations Specialist; sales support | Total investments: 0 | Find email | |
Gerard Philips
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
Getin Schraa
Global Lead – eCommerce
|
Global Lead – eCommerce | Total investments: 0 | Find email | |
|
Hayden Vivash
Financial Director
|
Financial Director | Total investments: 0 | Find email | |
|
Joanna Rogers
Commercial Leader UK & Ireland
|
Commercial Leader UK & Ireland | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| B-Soft provides information technology solutions and services for the healthcare industry in China.The company offers venture hospital information platform products, laboratory information systems, entrepreneurship medical management information systems, mobile products, venture medical imaging systems, venture electronic medical records systems,and many other products.B-Soft was established in 1997 and is headquartered in Hangzhou, China. | $180.4M / Post-IPO Equity / May 13, 2022 | ||
| CVAid Medical develops an innovative AI based stroke detection technological platform. | $4M / Series A / Feb 23, 2022 | ||
| Pulse Medical Technology develops innovative technology for the diagnosis and optimal treatment of pan-vascular diseases. | $100M / Series C / Aug 02, 2021 | ||
| Allm is a medical ICT company dedicated to shaping healthcare. The company seeks to benefit society by launching next-generation technologies and medical communications platforms for the healthcare industry. The solutions are installed more than 18 countries across US, South America, EU, Japan, Middle East and Africa. | $50.8M / Series A / Apr 05, 2021 | ||
| Babyscripts’ three-tiered approach to virtual maternity care allows providers to deliver risk-specific care to pregnant mothers at any time, in any place. The first tier consists of a digital education layer delivered via a mobile app, with daily gestational-age and practice-specific, customizable content extending through one year postpartum toengage and empower pregnant mothers through trusted resources. The second tier enables virtual management of pregnant patients through the addition of remote monitoring. Depending on the risk, patients are provided with medical devices (like a bluetooth-enabled blood pressure cuff) to monitor for elevated risk, alerting the provider through a unique trigger alert system to enable risk management and intervention. This smart end-to-end management of patients enables the provider to transition care outside of the clinic and address problems of access, allowing them to automate a majority of their patient care while more effectively allocating time and resources to higher-risk patients. The third tier brings the insurer into the equation in a unique collaboration between the care team and payer, solving some of the structural issues of care coordination and access to care, improving outcomes while reducing cost. | $6M / Corporate Round / Jan 07, 2019 | ||
| Allm is a medical ICT company dedicated to shaping healthcare. The company seeks to benefit society by launching next-generation technologies and medical communications platforms for the healthcare industry. The solutions are installed more than 18 countries across US, South America, EU, Japan, Middle East and Africa. | $241M / Oct 30, 2018 | ||
| Amwell is a telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The company offers a single, comprehensive platform to support alltelehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers telehealth solutions for over 240 health systems comprised of 2,000 hospitals and 55 health plan partners with over 36,000 employers, reaching over 150 million lives.Amwell was founded in 2006 and is headquartered in Boston, Massachusetts. | $290.6M / Corporate Round / Jul 03, 2018 | ||
| Oranger is a developer of portable wearable medical devices, focused on the treatment of medical-grade chronic respiratory diseases such as sleep apnea. | Series B / Jun 14, 2018 | ||
| Common Sensing develops and manufactures data-driven hardware and software medical device solutions for diabetes care that foster education and communication for patients while delivering decision support for clinicians. Common Sensing has a team of talented designers and engineers to develop Gocap™, a smart cap that turns existing injector pensinto smart injectors. | $6.6M / Series A / Apr 11, 2018 | ||
| Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized precision engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale. | $3.5M / Series A / Apr 07, 2016 | ||
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Philips invest in?
Philips invests primarily in Health Care, Software and Information Technology startups, most often at Funding Round and Series A stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Philips invest in?
Philips typically joins rounds of $3.5M–$51M at Series A and $20M–$74M at Series B. These are whole funding-round sizes, not Philips's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Philips took part in.
How do I contact Philips?
Public channels for Philips include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Philips?
The team at Philips includes Andrew Cabamalan (Commercial Operations Specialist; sales support), Gerard Philips (Co-Founder) and Getin Schraa (Global Lead – eCommerce), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
